Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Micro-Particle Curcumin in Chronic Kidney Disease
NCT02369549Phase 3Completed
- Start
- Sep 2015
- Primary completion
- Nov 2019
- Modality
- Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in chronic kidney disease (CKD) comparing Micro-particle curcumin with Placebo (2 arms). Primary endpoints: Change in albuminuria from baseline at 24 weeks and Change in Estimated Glomerular Filtration Rate at 24 weeks. Started Sep 2015; status: completed.
02
Drugs
curcumin
03
Conditions
chronic kidney disease (CKD)
Beyond the preview
Go deeper on NCT02369549.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02369549.